ReproCELL Statistics
Total Valuation
ReproCELL has a market cap or net worth of EUR 88.71 million. The enterprise value is 51.19 million.
| Market Cap | 88.71M |
| Enterprise Value | 51.19M |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 94.69M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.91% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 91.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.48 |
| PB Ratio | 1.86 |
| P/TBV Ratio | 1.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -29.08 |
| EV / Sales | 3.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.12
| Current Ratio | 5.12 |
| Quick Ratio | 4.80 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -3.67% and return on invested capital (ROIC) is -4.43%.
| Return on Equity (ROE) | -3.67% |
| Return on Assets (ROA) | -3.62% |
| Return on Invested Capital (ROIC) | -4.43% |
| Return on Capital Employed (ROCE) | -7.03% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 138,219 |
| Profits Per Employee | -17,778 |
| Employee Count | 99 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 4.15 |
Taxes
| Income Tax | -287,905 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.18% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -33.18% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.82 |
| Relative Strength Index (RSI) | 56.85 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ReproCELL had revenue of EUR 13.68 million and -1.76 million in losses. Loss per share was -0.02.
| Revenue | 13.68M |
| Gross Profit | 6.75M |
| Operating Income | -3.41M |
| Pretax Income | -2.05M |
| Net Income | -1.76M |
| EBITDA | -3.09M |
| EBIT | -3.41M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 37.20 million in cash and n/a in debt, with a net cash position of 37.20 million.
| Cash & Cash Equivalents | 37.20M |
| Total Debt | n/a |
| Net Cash | 37.20M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 47.74M |
| Book Value Per Share | 0.50 |
| Working Capital | 33.27M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 49.31%, with operating and profit margins of -24.89% and -12.86%.
| Gross Margin | 49.31% |
| Operating Margin | -24.89% |
| Pretax Margin | -14.97% |
| Profit Margin | -12.86% |
| EBITDA Margin | -22.56% |
| EBIT Margin | -24.89% |
| FCF Margin | n/a |
Dividends & Yields
ReproCELL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.91% |
| Shareholder Yield | -3.91% |
| Earnings Yield | -1.98% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 28, 2013. It was a forward split with a ratio of 5.
| Last Split Date | Aug 28, 2013 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
ReproCELL has an Altman Z-Score of 6.6 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.6 |
| Piotroski F-Score | 1 |